Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
{{output}}
Interindividual differences in drug disposition are important causes for adverse drug reactions and lack of drug response. The majority of phase I and phase II drug-metabolizing enzymes (DMEs) are polymorphic and constitute essential factors for the outcome of... ...
